Skip to content
New Arthritis Drug Xeljanz Gets FDA Approval
avatar
Caprice_WebMD_Staff posted:
Nov. 6, 2012 -- The FDA has approved Pfizer's Xeljanz (tofacitinib), a first-of-its-kind treatment for rheumatoid arthritis .

Xeljanz is approved for use by patients not helped by methotrexate , the usual first treatment for RA. It's a pill taken twice a day.

Xeljanz is a type of drug called a Janus kinase or JAK inhibitor. Blocking JAK mutes the inflammation responses responsible for RA.
"Xeljanz provides a new treatment option for adults suffering from the debilitating disease of RA who have had a poor response to methotrexate," says Badrul Chowdhury, MD, PhD, the FDA's head of pulmonary, allergy , and rheumatology products.
We must let go of the life we have planned, so as to accept the one that is waiting for us. ~Joseph Campbell
Was this Helpful?
2 of 2 found this helpful
Reply
 
avatar
lex16420 responded:
@25k a year
 
avatar
xperky replied to lex16420's response:
Yikes


Featuring Experts

Scott Zashin, MD is a clinical assistant professor at the University of Texas, Southwestern Medical School and maintains a private practice at Presb...More

Helpful Tips

help with methotrexate side effectsExpert
I recommend all my patients on methotrexate take at least 1 mg of Folic Acid daily to help decrease the risk of side effects. In those ... More
Was this Helpful?
27 of 30 found this helpful

Related News

There was an error with this newsfeed

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.